Blue Jet Healthcare Limited (BLUEJET.NS)
INR 584.5
(1.93%)
INR 584.5
(1.93%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 531.85 Million INR | 55.21% |
| 2022 | 739.55 Million INR | -0.26% |
| 2021 | 741.46 Million INR | 18.88% |
| 2020 | 623.68 Million INR | -51.22% |
| 2019 | 1.27 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 538.74 Million INR | 12.71% |
| 2024 Q1 | 300.41 Million INR | -2.38% |
| 2023 Q2 | 270.96 Million INR | 43.12% |
| 2023 Q3 | 283.06 Million INR | 4.47% |
| 2023 Q1 | 189.33 Million INR | -57.11% |
| 2023 Q4 | 307.73 Million INR | 8.72% |
| 2023 FY | 1.14 Billion INR | 55.21% |
| 2022 Q1 | 174.01 Million INR | 0.0% |
| 2022 FY | 739.55 Million INR | -0.26% |
| 2022 Q4 | 441.41 Million INR | -7.85% |
| 2022 Q3 | 478.99 Million INR | 20.98% |
| 2022 Q2 | 395.93 Million INR | 127.54% |
| 2021 FY | 741.46 Million INR | 18.88% |
| 2020 FY | 623.68 Million INR | -51.22% |
| 2019 FY | 1.27 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Biocon Limited | 40.9 Billion INR | 98.7% |
| Concord Biotech Limited | 1.45 Billion INR | 63.565% |
| Dishman Carbogen Amcis Limited | 5.14 Billion INR | 89.668% |
| Jubilant Ingrevia Limited | 6.67 Billion INR | 92.026% |
| Lyka Labs Limited | 599.4 Million INR | 11.271% |
| Panacea Biotec Limited | 1.99 Billion INR | 73.346% |
| Piramal Pharma Limited | 19.91 Billion INR | 97.329% |
| SMS Lifesciences India Limited | 602.96 Million INR | 11.795% |
| Supriya Lifescience Limited | 1.08 Billion INR | 50.761% |
| Syngene International Limited | 5.99 Billion INR | 91.128% |
| TAKE Solutions Limited | 396.91 Million INR | -33.998% |
| Zota Health Care Limited | 457.83 Million INR | -16.166% |